Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Jan 05, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000010.pdf 0001883850-22-000010.xls
Jan 05, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000012.pdf 0001883850-22-000012.xls
Dec 23, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-21-000034.pdf 0001883850-21-000034.xls
Dec 20, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-21-000032.pdf 0001883850-21-000032.xls
Dec 14, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-21-000029.pdf 0001883850-21-000029.xls
Dec 14, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-21-000028.pdf 0001883850-21-000028.xls
Dec 14, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-21-000030.pdf 0001883850-21-000030.xls
Dec 14, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000103.pdf 0001708138-21-000103.xls
Dec 14, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000104.pdf 0001708138-21-000104.xls
Dec 14, 2021	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-21-000105.pdf 0001708138-21-000105.xls

Data provided by Kaleidoscope.

Investors & Media